- Naveris Announces Commercial Payor Coverage for NavDx® Test from Highmark, Inc.
- Naveris Receives Medicare Coverage for NavDx® Test
- Naveris Announces Two Peer-Review Publications Validating NavDx® Performance in Daily Clinical Practice
- Naveris Announces New Data Featuring NavDx® in Oral Highlight and Poster Presentations at Upcoming ASTRO and AAO-HNSF 2023 Meetings
- Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial